Clinical Trial Update: Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of combining hypoxia-targeting therapy with an ARSI after first-line ARSI in castration-resistant prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Castration Resistant Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING